Tag: biopharmaceuticals
-
Lighthouse Pharmaceuticals to Present Phase 2 SPRING Trial of LHP588 at CTAD 2025
Overview of the SPRING Trial and LHP588 Lighthouse Pharmaceuticals, a Novato, California-based clinical-stage biopharmaceutical company, is poised to share new data from its Phase 2 SPRING trial of LHP588, a next-generation gingipain inhibitor designed to address P. gingivalis-positive Alzheimer’s disease. Gingipains are enzymes produced by the oral bacterium Porphyromonas gingivalis, which researchers have linked to…
-
Innovent Highlights Broad Biomedicine Pipeline at 2025 ACR Annual Meeting
Innovent Showcases Broad Biomedicine Pipeline at 2025 ACR Annual Meeting Innovent Biologics, a leading biopharmaceutical company focused on developing, manufacturing, and commercializing high-quality medicines, today highlighted multiple research results from its general biomedicine pipeline at the 2025 American College of Rheumatology (ACR) Annual Meeting. The event, held in San Francisco with contributions from Innovent’s teams…
-
Innovent Highlights: General Biomedicine Pipeline Showcased at 2025 ACR Annual Meeting
Innovent Unveils Progress Across the General Biomedicine Pipeline at the 2025 ACR Annual Meeting The 2025 ACR Annual Meeting in San Francisco and nearby venues became a hub for researchers and industry leaders as Innovent Biologics, a global biopharmaceutical company, highlighted several milestones from its General Biomedicine Pipeline. The presentations underscored a commitment to advancing…